Inventor
Uma Sinha
Inventor
San Francisco, CA, US
Overview
Patents· 29 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes24%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations22%
C07KPeptides16%
C12NMicroorganisms or enzymes16%
C12YEnzymes16%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests5%
C07DHeterocyclic compounds2%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms1%
PatentTitleYear
11,058,668Methods of treating TTR amyloidosis using AG10202110,765,726Unit dose formulation of antidotes for factor Xa inhibitors and methods of using the same202010,675,335Antidotes for factor Xa inhibitors and methods of using the same202010,190,111Antidotes for factor Xa inhibitors and methods of using the same201910,004,725Methods of treatment20189,587,233'Antidotes for factor XA inhibitors and methods of using the same'20179,388,401'Antidotes for factor Xa inhibitors and methods of using the same'20169,109,046'Antidotes for factor Xa inhibitors and methods of using the same'20159,062,298'Antidotes for factor XA inhibitors and methods of using the same'20159,056,106'Unit dose formulation of antidotes for factor Xa inhibitors and methods of using the same'20159,023,796'Antidotes for factor XA inhibitors and methods of using the same'20158,946,219'Combination therapy with a compound acting as a platelet ADP receptor inhibitor'20158,889,129'Antidotes for factor Xa inhibitors and methods of using the same'20148,455,440'Combination anticoagulant therapy with a compound that acts as a factor Xa inhibitor'20138,455,439'Antidotes for factor Xa inhibitors and methods of using the same in combination with blood coagulating agents'20138,455,441'Antidotes for factor Xa inhibitors and methods of using the same'20138,404,724'Unit dose formulations and methods of treating thrombosis with an oral factor Xa inhibitor'20138,268,783'Antidotes for factor Xa inhibitors and methods of using the same'20128,153,590'Antidotes for factor Xa inhibitors and methods of using the same'20126,245,743'Inhibitors of factor Xa'20016,117,836'Glycosylation-mediated inhibition of factor X'20006,046,169'Inhibitors of factor XA'20005,990,079'Agents affecting thrombosis and hemostasis'19995,968,897'Agents affecting thrombosis and hemostasis'19995,919,765'Inhibitors of factor XA'19995,837,679'Agents affecting thrombosis and hemostasis'19985,798,332'Glycosylation-mediated inhibition of factor X'19985,721,214'Inhibitors of factor Xa'19985,583,107'Agents affecting thrombosis and hemostasis'1996Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1996–2001Patents assigned to COR THERAPEUTICS INC (10)· patent assignee history
1996–2021Based in San Francisco, CA, US· patent location history
2012–2020Patents assigned to PORTOLA PHARM INC (14)· patent assignee history
2012–2015Patents assigned to SINHA UMA (9)· patent assignee history
2012–2015Patents assigned to LU GENMIN (6)· patent assignee history
2012–2015Patents assigned to ANDRE PATRICK (4)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| PORTOLA PHARM INC | 14 | 2012–2020 |
| COR THERAPEUTICS INC | 10 | 1996–2001 |
| SINHA UMAself | 9 | 2012–2015 |
| LU GENMIN | 6 | 2012–2015 |
| ANDRE PATRICK | 4 | 2012–2015 |
Locations
| Location | Patents | Span |
|---|---|---|
| San Francisco, California, US | 29 | 1996–2021 |